One would be crazy to short now as MSB hasn't reached 85c, the price that is equiv to pre-fall (dililution taken cate of) when it was only speculative that FDA would be happy. Now we have the ticked that box re pediactroc trial data (no speculation), BLA is just a formality and two FDA approvals have been achieved. So, 85c is inevitable. So, doesn't sound logical to short ... in any case as a LT holder that is not relevant for me. Science is right, technology is right. All a matter of time, and that time is within reach now ... I would say next quarter is the REAL turning point, once BLA all done and dealt with.
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-438
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.005(0.34%) |
Mkt cap ! $1.649B | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.49 | $1.44 | $1.552M | 1.066M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 29983 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 35244 | 10 |
View Market Depth
| Last trade - 11.31am 21/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |